tiprankstipranks
Incyte Corp (INCY)
NASDAQ:INCY
Want to see INCY full AI Analyst Report?

Compare Incyte (INCY) vs. Competitors

1,911 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Incyte
$97.82
$19.41B
15.46
55.35%
8 Buy
10 Hold
1 Sell
Moderate Buy
BioMarin Pharmaceutical
$54.64
$10.67B
25.76
-10.59%
14 Buy
4 Hold
0 Sell
Strong Buy
Exelixis
$44.89
$11.22B
12.10
11.54%
6 Buy
6 Hold
1 Sell
Moderate Buy
United Therapeutics
$588.38
$25.47B
14.81
97.29%
10 Buy
4 Hold
0 Sell
Moderate Buy
Ascendis Pharma
$244.48
$14.27B
-83.76
32.92%
13 Buy
0 Hold
0 Sell
Strong Buy
Genmab
$28.55
$15.95B
153.52
25.88%
8 Buy
2 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
INCY
Incyte
97.14
37.53
62.96%
BMRN
BioMarin Pharmaceutical
55.46
-4.18
-7.01%
EXEL
Exelixis
44.17
7.31
19.83%
UTHR
United Therapeutics
581.22
286.20
97.01%
ASND
Ascendis Pharma
228.71
65.87
40.45%
GMAB
Genmab
27.04
6.62
32.42%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts